Patents Assigned to Mineralys Therapeutics, Inc.
  • SOLUBLE PHARMACEUTICAL COMPOSITIONS COMPRISING SALTS OF DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND
    Publication number: 20240366616
    Abstract: Disclosed are pharmaceutical compositions comprising a salt of a compound having the formula: and one or more excipients, wherein the pharmaceutical composition avoids inducing disproportionation of the salt of the compound.
    Type: Application
    Filed: July 20, 2022
    Publication date: November 7, 2024
    Applicants: Mineralys Therapeutics, Inc., Mitsubishi Tanabe Pharma Corporation
    Inventors: Robert McKean, Roch Thibert, Elizabeth Vadas, Yoshinori Ohashi, Fuminori Ozaki, Hiroki Ohshima, Hiroomi Nagata
  • CYP11B2 BETA HYDROXYLASE INHIBITORS FOR HYPERTENSION
    Publication number: 20240009201
    Abstract: The disclosure provides, inter alia, methods to treat hypertension in patients using CYP 11?2 beta hydroxylase inhibitors.
    Type: Application
    Filed: October 25, 2021
    Publication date: January 11, 2024
    Applicant: Mineralys Therapeutics, Inc.
    Inventors: Brian Taylor Slingsby, William Connolly Watt, David Rodman